Reynoso-von DC, Balderrama-Vargas C, Martínez-Baumbach EB, Tinoco-Ventura E, Rodríguez-Mora E

Language: Spanish
References: 18
Page: 427-430
PDF size: 144.35 Kb.

ABSTRACT

Bullous pemphigoid is an autoimmune dermatosis characterized by deposition of immunoglobulin G (IgG) and/or complement along basement membrane zone. The lesions of bullous pemphigoid are tense blisters on trunk and extremities, oral lesions are unusual. Figurate erythema includes some dermatologic pictures characterized by annular and polycyclic lesions. Figurate erythema can be confused with erythema gyratum repens, dermatosis associated statistically to malignant neoplasias. The objective for reporting this case is to inform the simultaneous association between bullous pemphigoid and figurate erythema in 83 year old man without underlying malignancy.

REFERENCES

1. Kuenzli S, Grimaître M, Krischer J, Saurat JH, Calza AM, Borradori L. Childhood bullous pemphigoid: report of a case with life-threatening course during homeopathy treatment. Pediatr Dermatol 2004;21: 160-163.

2. Amos B, Deng J, Flynn K, Suarez S. Bullous pemphigoid in infancy: case report and literature review. Pediatr Dermatol 1998;15;108-111.

3. Korman NJ. Bullous pemphigoid. Arch Dermatol 1998;134:1137-1141.

4. Siddiqui MA, Zaman MN. Recurrent and chronic leg ulcers secondary to furosemide-induced bullous pemphigoid. J Am Geriatr Soc 1995;43: 1183-1184.

5. William MAJ. Bullous pemphigoid, miasthenia gravis and thymoma. Arch Dermatol 1984;120:397.

6. Stoll DM, King LE. Assotiation of bullous pemphigoid with systemic lupus erytematosus. Arch Dermatol 1984;120:362-366.

7. Patterson JM, Murray JC, Hazra TA. Bullous pemphigoid. Occurrence in a patient with mycosis fungoides receiving PUVA and topical nitrogen mustard therapy. Int J Dermatol 1985;24:173-176.

8. Burgdorf WHC. Erythema annulare centrigugum and other figurate erythemas. En: Fitzpatrick T, Eisen AZ, Wolff K, Freedberg IM, Austen KF, editors. Dermatology in general medicine. USA: McGraw Hill; 1993. p. 1183-1186.

9. Wojnarowska P, Kirtschig G, Highet AS, Venning VA, Khumalo NP. Guidelines for the management of bullous pemphigoid. Br J Dermatol 2002;147: 214-221.

10. Iranzo P, López I, Robles MR, Mascaró JM, Campo E, Herrero C. Bullous pemphigoid associated with mantle cell lymphoma. Arch Dermatol 2004;140: 1496-1499.

11. Weedon D, Strutton G. Piel. Patología. Madrid: Marban; 2002 p. 135-138.

12. Muramatsu T, Hda T, Tada H, Hatoko M, Kobayashi N, Ko T, Shirai T. Bullous pemphigoid associated with internal malignancies: identification of 180 kDa antigen by Western immunoblotting. Br J Dermatol 1996;135:782-784.

13. Saikia NK, Rona M, Mackie, McQueen. A case of bullous pemphigoid and figurate erythema in association with metastatic spread carcinoma. Br J Dermatol 1973;88:331-334.

14. Hauschild A, Swensson O, Christophers E. Paraneoplastic bullous pemphigoid resembling erythema gyratum repens. Br J Dermatol 1999;140:550-552.

15. McLean D, Haynes HA. Cutaneous manifestations of internal malignant disease. En: Fitzpatrick T, Eisen AZ, Wolff K, Freedberg IM, Austen KF, editors. Dermatology in general medicine. USA. McGraw Hill; 1993. p. 2229-2249.

16. Stern RS. Bullous Pemphigoid therapy- think globally, act locally. N Engl J Med 2002;346:364-367.

17. Guillaume JC, Vaillant L, Bernard P, Picard C, Prost C, Labeille B,et. Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment bullous pemphigoid. Arch Dermatol 1993;129:49-53.

18. Jolles S, Hoghes J, Whittaker S. Dermatological uses of high-dose intravenous immunoglobulin. Arch Dermatol 1998;134:80-86.